Macrogenics (MGNX) Long-Term Investments (2016 - 2026)

Macrogenics (MGNX) has 11 years of Long-Term Investments data on file, last reported at $87.7 million in Q1 2026.

• On a quarterly basis, Long-Term Investments rose 923.36% year-over-year to $87.7 million in Q1 2026; TTM through Mar 2026 was $87.7 million, a 923.36% increase from a year earlier, with the FY2025 full-year figure at $132.7 million, up 605.83% from the prior year.
• Long-Term Investments for Q1 2026 stood at $87.7 million, down from $132.7 million in the prior quarter.
• Over the last five years, Long-Term Investments for MGNX reached as high as $166.5 million in Q3 2023 and fell as low as $8.6 million in Q1 2025.
• Historically, Long-Term Investments has averaged $77.6 million across 5 years, with a median of $66.3 million in 2025.
• Across the five-year window, Long-Term Investments plunged 91.75% in 2025 and surged 923.36% in 2026, its largest moves.
• Year by year, Long-Term Investments stood at $45.5 million in 2022, then soared by 183.18% to $128.8 million in 2023, then plunged by 85.41% to $18.8 million in 2024, then soared by 605.83% to $132.7 million in 2025, then plunged by 33.9% to $87.7 million in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $87.7 million in Q1 2026, $132.7 million in Q4 2025, and $66.3 million in Q3 2025.